SESSION 11 SCHEDULE
Thursday
SESSION 11: NEW DEVELOPMENTS IN ENDOVASCULAR HEART VALVES AND APPROACHES TO TREAT THORACIC AORTIC LESIONS (5-MINUTE TALKS)
Moderators:Roy K. Greenberg, MD / Lars G. Svensson, MD, PhD  
x
6:35 AM - 6:40 AM Opening Remarks
  Presenters(s):Frank J. Veith, MD  
6:40 AM - 6:45 AM Direct Minimally Invasive Videoscopic Approach To The Thoracic Aorta For Delivery Of Aortic Endografts
  Presenters(s):Willem Wisselink, MD  
6:46 AM - 6:51 AM A New Embolic (Brain) Protection Device During Endovascular Aortic Arch And Valve Procedures To Prevent Strokes By Covering Orifices Of Supra-aortic Trunk
  Presenters(s):Jeffrey P. Carpenter, MD  
6:52 AM - 6:57 AM Venous Trans-Septal Access To The Aorta And Its Branches: How Is It Done And When Can It Be Helpful?
  Presenters(s):Tilo Kölbel, MD, PhD  
6:58 AM - 7:03 AM Future Of Transcatheter Valves: What Will Be Left For Classical Operations: A Surgeon’s View
  Presenters(s):Todd M. Dewey, MD / Michael J. Mack, MD  
7:04 AM - 7:09 AM Status Of Transcatheter Aortic Valve Repair: What Will Be Left For Classical Operations? A Cardiologist’s View
  Presenters(s):Horst Sievert, MD  
7:10 AM - 7:15 AM Status Of Percutaneous Mitral Valve Repair: Have There Been Improvements In Devices And Techniques?
  Presenters(s):Ted Feldman, MD  
7:16 AM - 7:21 AM Intra-Thoracic Debranching Can Simplify The Approach To Type II Thoracoabdominal Aortic Aneurysms (TAAAs)
  Presenters(s):Patrice F. Bergeron, MD  
7:22 AM - 7:27 AM Treatment Of Extensive Arch And Thoracic Aneurysms With Staged Open And Endograft Techniques Using The Evita Endograft: Revascularization Of Aortic Branches
  Presenters(s):Piotr M. Kasprzak, MD  
7:28 AM - 7:33 AM Overcoming The Challenge Of Thoracic Endograft Compression: Is Increased Radial Force The Answer?
  Presenters(s):Dittmar Boeckler, MD  
7:34 AM - 7:44 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 11.1 - Laparoscopically Assisted TEVAR Via The Aorta Or Common Iliac Artery When Femoral And External Iliac Access Is Impossible
  Presenters(s):Ralf R. Kolvenbach, MD  
Web-Based Presentation 11.2 - Primary And Secondary Aorto-Esophageal And Aortobronchial Fistulas And Their Modern Treatment
  Presenters(s):Roberto Chiesa, MD  
Web-Based Presentation 11.3 - Comparative Analysis Of Open And Endovascular Repair Of Ruptured Descending Thoracic Aortic Aneurysms (RTAAs)
  Presenters(s):Gilbert R. Upchurch, MD  
Web-Based Presentation 11.4 - Neurological Complications Of TEVAR And Their Management: Paraplegia Is Reversible Whereas Stroke Is Not
  Presenters(s):Peter R. Taylor, MA, MChir, FRCS  
Web-Based Presentation 11.5 - Is Spinal Ischemia With TEVAR More Of A Problem When Patients Have A Previous AAA Repair?
  Presenters(s):Carlo Setacci, MD  
END OF SESSION 11
 
SESSION 12 SCHEDULE
Thursday
SESSION 12: NEW DEVELOPMENTS IN TREATMENT OF THORACIC AND THORACOABDOMINAL AORTIC DISEASE (5-MINUTE TALKS)
Moderators:Edward B. Diethrich, MD / Peter R. Taylor, MA, MChir, FRCS  
x
7:45 AM - 7:50 AM Simplified Arch Aneurysm Treatment With Fenestrated Endografts: How Can It Work And Initial Experience
  Presenters(s):Yoshihiko Yokoi, MD / Hiroshi Shigematsu, MD, PhD  
7:51 AM - 7:56 AM Debate 1: New Developments In Branched And Fenestrated Endografts Suggest There Will Be No Role For Open Surgery In Repair Of TAAAs
  Presenters(s):Stephan Haulon, MD  
7:57 AM - 8:02 AM Debate 1: There Will Always Be A Role For Open Surgical Repair Of TAAAs Even With Improved Endografts
  Presenters(s):Michael J. Jacobs, MD  
8:03 AM - 8:08 AM Open And Endovascular Repair Of Descending Thoracic Aortic Aneurysms: There Is A Role For Both: What Is It?
  Presenters(s):Roberto Chiesa, MD  
8:09 AM - 8:14 AM Exclusion Of Ascending Aorta And Aortic Arch Aneurysms Is Now Feasible By A Totally Endovascular Approach
  Presenters(s):Ralf R. Kolvenbach, MD  
8:15 AM - 8:20 AM Experience With A New Simplified Device To Treat Aortic Arch Aneurysms With Branched Endografts And Other Possible Future Designs
  Presenters(s):Krassi Ivancev, MD, PhD / David E. Hartley, FRANZCR (Hon)  
8:21 AM - 8:26 AM Advances In In Situ Fenestration For Total Endovascular Arch Repair To Improve Branch Stability And Maintain Brain Perfusion During The Procedure
  Presenters(s):Bjõrn Sonesson, MD, PhD  
8:27 AM - 8:32 AM Debate 2: Properly Constructed Chimney Or Snorkel Grafts Can Work To Revascularize Aortic Arch Branches
  Presenters(s):Armando C. Lobato, MD, PhD  
8:33 AM - 8:38 AM Debate 2: Mechanical Stress And Strains On Branches In The Aortic Arch Mean Chimney Grafts Won’t Work Well Here
  Presenters(s):Jacques Bleyn, MD  
8:39 AM - 8:48 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 12.1 - A Novel More Effective Glue-Sealant (ArterX) For Hemostasis At Vascular Suture Lines And Other Sites
  Presenters(s):William M. Stone, MD / Samuel R. Money, MD, MBA  
Web-Based Presentation 12.2 - New Hybrid Procedures For Ascending Aorta And Arch Reconstructions To Treat Difficult Aneurysms
  Presenters(s):Christoph A. Nienaber, MD, PhD  
Web-Based Presentation 12.3 - In Situ Retrograde Arch Fenestration Techniques Are Going To Become Standard To Repair Arch Lesions: Current Technique And Experience
  Presenters(s):Furuzan Numan, MD  
Web-Based Presentation 12.4 - Device Designs To Meet The Challenges Of The Aortic Arch
  Presenters(s):Wei Guo, MD  
END OF SESSION 12
 
SESSION 13 SCHEDULE
Thursday
SESSION 13: NEW DEVELOPMENTS IN STENT-GRAFTS, STENTS AND TECHNIQUES FOR TREATING THORACIC AORTIC LESIONS: MORE ABOUT COMPLICATIONS AND PATHOLOGY (5-MINUTE TALKS)
Moderators:Krassi Ivancev, MD, PhD / Nicholas J.W. Cheshire, MD  
x
8:49 AM - 8:54 AM Pathogenesis, Prevention And Treatment Of Retrograde Type A Dissection After TEVAR And Open Surgery
  Presenters(s):Rodney A. White, MD  
8:55 AM - 9:00 AM Perspective On The Causes, Prevention And Treatment Of Type A Dissections As A Complication Of TEVAR For Type B Dissections
  Presenters(s):Burkhart Zipfel, MD  
9:01 AM - 9:06 AM Endograft Treatment Of Type A Dissection: Real And Theoretical Systems Will Make This Feasible
  Presenters(s):Christoph A. Nienaber, MD, PhD  
9:07 AM - 9:12 AM Dynamic MR In Type B Dissections: Value In Determining Flap Mobility And Organ Perfusion; And In Guiding Treatment
  Presenters(s):Alan B. Lumsden, MD, FACS  
9:13 AM - 9:18 AM Indications, Techniques And Outcomes After Endovascular Treatment Of Chronic Type B Aortic Dissections In Patients With And Without Marfan’s Syndrome
  Presenters(s):Geoffrey H. White, MD  
9:19 AM - 9:24 AM Techniques For Endograft Treatment Of Dissecting Aortic Aneurysms Involving All Or Part Of The Arch: The "Miracle Technique" For Revascularization Of Arch Branches
  Presenters(s):Zaiping Jing, MD  
9:25 AM - 9:30 AM Update On The STABLE Trial With A Proximal Endograft And A Distal Uncovered Stent
  Presenters(s):Joseph V. Lombardi, MD  
9:31 AM - 9:36 AM Improving Distal Fixation And Sealing In Thoracic Endografting With A Distal Graft Scallop For Visceral Arteries: Precautions And Results
  Presenters(s):Vicente Riambau, MD, PhD  
9:37 AM - 9:42 AM Strategies For Complex Hybrid Aortic Endografting
  Presenters(s):Edward B. Diethrich, MD  
9:43 AM - 9:48 AM Technique For Rapid Pacing And How It Helps In The Better Deployment Of Thoracic Endografts
  Presenters(s):Dietmar H. Koschyk, MD  
9:49 AM - 9:55 AM Panel Discussion
9:50 AM - 10:05 AM Break / Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 13.1 - Lessons Learned In 460 TEVARs: Mistakes That Can Be Avoided
  Presenters(s):W. Anthony Lee, MD  
Web-Based Presentation 13.2 - More Extensive Aortic Coverage By TEVAR In Type B Dissections Produces Better Outcomes
  Presenters(s):Matt M. Thompson, MD  
Web-Based Presentation 13.3 - Endovascular Methods Other Than Endografts For Treating Thoracic Aortic Aneurysms
  Presenters(s):James May, MD, MS, FRACS, FACS  
Web-Based Presentation 13.4 - Early Clinical Experience With Endovascular Treatment Of Type A Dissecting Aneurysms
  Presenters(s):Matt M. Thompson, MD  
Web-Based Presentation 13.5 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Beneficial
  Presenters(s):Rodney A. White, MD  
Web-Based Presentation 13.6 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Not Beneficial
  Presenters(s):Jan S. Brunkwall, MD, PhD  
Web-Based Presentation 13.7 - Lessons Learned From Pathologic Exam After TEVAR Failure
  Presenters(s):Alan B. Lumsden, MD, FACS  
END OF SESSION 13
 
SESSION 14 SCHEDULE
Thursday
SESSION 14: LOWER EXTREMITY ENDOVASCULAR HOT TOPICS - PART 1 (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Alan M. Graham, MD  
x
6:40 AM - 6:45 AM Opening Remarks
  Presenters(s):Frank J. Veith, MD  
6:45 AM - 6:50 AM Results With Jetstream Atherectomy/Thrombectomy In Infrainguinal Arterial Disease: What Makes It Different From Other Devices?
  Presenters(s):Venkatesh G. Ramaiah, MD  
6:51 AM - 6:56 AM Importance Of Embolization During Lower Extremity Endovascular Procedures: How Can It Be Prevented And Treated?
  Presenters(s):Nicholas J. Morrissey, MD  
6:57 AM - 7:02 AM The ANGIOSLIDE Balloon Catheter To Capture Embolic Material Released During Lower Extremity Angioplasty: A New Concept In Distal Embolic Protection
  Presenters(s):Gunnar Tepe, MD  
7:03 AM - 7:08 AM Multicenter Belgian-Italian Trial Evaluating The Long-Term (Up To 24 Months) Outcome Of The Self-Expanding Nitinol Absolute Pro And The Balloon-Expandable Omnilink Elite Stent In TASC A & B And TASC C & D Iliac Lesions In 325 Patients
  Presenters(s):Patrick Peeters, MD  
7:09 AM - 7:14 AM Debate 3: Atherectomy Really Works Better Than POBA: Why Can’t Others Reproduce The Good Results?
  Presenters(s):James F. McKinsey, MD  
7:15 AM - 7:20 AM Debate 3: Atherectomy Really Does Not Work Very Well Even Though I Tried It
  Presenters(s):Julio A. Rodriguez-Lopez, MD  
7:21 AM - 7:26 AM Tips, Tricks, Techniques And Indications In Pedal Artery Access
  Presenters(s):Craig M. Walker, MD  
7:27 AM - 7:32 AM Can Diabetics With Neuropathy Have Their Symptoms Relieved By PTA: Do The Symptoms Recur With Restenosis?
  Presenters(s):Alan E. Bray, MD, FRACS  
7:33 AM - 7:39 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 14.1 - How Do We Know Atherectomy Works?
  Presenters(s):Gary M. Ansel, MD  
Web-Based Presentation 14.2 - Value Of Drug Eluting Balloons In Below The Knee Artery PTAs
  Presenters(s):Marco G. Manzi, MD  
Web-Based Presentation 14.3 - Tips And Tricks And New Techniques For Crossing Difficult SFA And Popliteal Occlusions: Is The Radiofrequency Wire Going To Help And How Can It Be Used?
  Presenters(s):Andrej Schmidt, MD, PhD  
Web-Based Presentation 14.4 - Use Of Standardized Percutaneous Techniques For SFA And Popliteal Artery TASC C And D Lesions Improves Outcomes
  Presenters(s):Manish Mehta, MD, MPH  
END OF SESSION 14
 
SESSION 15 SCHEDULE
Thursday
SESSION 15: LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, FACS, FACC / Gary Giangola, MD  
x
7:40 AM - 7:45 AM Why We Should Still Perform Pedal Bypasses In Some Patients
  Presenters(s):Werner Lang, MD  
7:46 AM - 7:51 AM Mid-Term Experience With Drug Eluting Balloons In SFA And Popliteal Arteries
  Presenters(s):Giancarlo Biamino, MD, PhD  
7:52 AM - 7:57 AM Debate 4: Stent Fractures In The SFA Do Matter: Let’s Look At The Data
  Presenters(s):Dierk Scheinert, MD  
7:58 AM - 8:03 AM Debate 4: Stent Fractures In The SFA Do Not Really Matter
  Presenters(s):Erich Minar, MD  
8:04 AM - 8:09 AM How Does Paclitaxil On Stents And Balloons Work To Prevent Restenosis?
  Presenters(s):Alberto Cremonesi, MD, FESC  
8:10 AM - 8:15 AM Drug-Eluting Stents Below The Knee - Promises And Limitations: Update On The DESTINY And ACHILLES Trials Comparing DE To Bare Metal Stents
  Presenters(s):Marc Bosiers, MD  
8:16 AM - 8:21 AM What Is The eXtra Balloon And What Is Its Value In Endovascular Interventions?
  Presenters(s):Gary M. Ansel, MD  
8:22 AM - 8:27 AM Debunking Another Surgical Myth: Stenting The CFA Is Always Bad And Must Be Avoided
  Presenters(s):Frank J. Criado, MD, FACS, FSVM  
8:28 AM - 8:33 AM Value Of Drug Eluting (Cypher) Stents For Critical Limb Ischemia (CLI) After Failed PTA: Favorable Mid-Term Patency And Limb Salvage Results
  Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA  
8:33 AM - 8:40 AM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 15.1 - SFA And Crural Endovascular Revascularization: How Does One Decide Which Method To Use?
  Presenters(s):Peter A. Schneider, MD  
Web-Based Presentation 15.2 - Optimal Treatment For In-Stent Restenosis In The SFA; Below The Knee
  Presenters(s):Craig M. Walker, MD  
Web-Based Presentation 15.3 - Does Cryoplasty Still Have A Role In The Treatment Of CLI?
  Presenters(s):Bauer E. Sumpio, MD, PhD  
END OF SESSION 15
 
SESSION 16 SCHEDULE
Thursday
SESSION 16: LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:Richard M. Green, MD / Michael F. Silane, MD  
x
8:41 AM - 8:46 AM Results Of A Phase 3 Trial Of Novel Targeted Angiogenic Therapy With NV1FGF For Critical Limb Ischemia
  Presenters(s):Iris Baumgartner, MD / Nicolas A. Diehm, MD  
8:47 AM - 8:52 AM Debate 5: Long-Term Outcomes Of PTA For CLI: Outcomes Justify A PTA First Strategy: But In Whhich Patients?
  Presenters(s):Mark Conrad, MD  
8:53 AM - 8:58 AM Debate 5: Failed PTA/Stent Is Associated With Reduced Patency Of Subsequent Bypass: A Study From The VSGNE Database
  Presenters(s):Jack L. Cronenwett, MD  
8:59 AM - 9:04 AM Retrograde Popliteal Access For SFA Recanalization: Indications, Technique And Results
  Presenters(s):Plinio Rossi, MD  
9:05 AM - 9:10 AM How To Do Popliteal Punctures And Procedures With The Patient In The Supine Position
  Presenters(s):Kiang Hiong Tay, MBBS, FRCR, FAMS, FSIR  
9:11 AM - 9:16 AM Patterns Of Recurrent Disease After SFA Interventions: How Should Such Recurrences Be Managed?
  Presenters(s):Robert Y. Rhee, MD  
9:17 AM - 9:22 AM Drug Eluting Balloons Improve Results Of PTA For Long Tibial Artery Lesions
  Presenters(s):Andrej Schmidt, MD, PhD  
9:23 AM - 9:28 AM Durability Of PTAs Using Pedal Artery Approaches
  Presenters(s):Craig M. Walker, MD  
9:29 AM - 9:34 AM Patient Selection For Drug Eluting Stents In The Lower Extremity
  Presenters(s):Dierk Scheinert, MD  
9:35 AM - 9:40 AM Below The Ankle Angioplasty: To Stent Or Not To Stent
  Presenters(s):Konstantinos Katsanos, MD  
9:41 AM - 9:47 AM Panel Discussion
9:48 AM - 10:05 AM Break / Visit Exhibits and Pavilions (2nd and 3rd Floors)

CONCLUSION OF PROGRAMS A AND B. MEETING CONTINUES IN THE GRAND BALLROOM (3rd FLOOR) AS PLENARY SESSIONS.
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 16.1 - How To Avoid Use Of Reentry Devices When Crossing Total Occlusions
  Presenters(s):Ali Amin, MD, RVT, FACS, FACC  
Web-Based Presentation 16.2 - Debate: Tibial Artery Lesions With CLI Do Better With Distal Open Bypasses
  Presenters(s):Hans-Henning Eckstein, MD, PhD  
Web-Based Presentation 16.3 - Debate: Tibial Artery Lesions With CLI Do Better With Endovascular Treatment
  Presenters(s):Iris Baumgartner, MD  
Web-Based Presentation 16.4 - Long Bare Nitinol Stents For TASC C And D Fem-Pop Lesions (The DURABILIITY Trial): How Well Do They Do?
  Presenters(s):Marc Bosiers, MD  
Web-Based Presentation 16.5 - Techniques And Advantages Of Treating Lower Extremity Disease With 4 French Systems: What Is Possible And What Is Not?
  Presenters(s):Andrej Schmidt, MD, PhD  
END OF SESSION 16
 
SESSION 17 SCHEDULE
Thursday
SESSION 17: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
Moderators:Dennis F. Bandyk, MD / Michael B. Silva, Jr., MD  
x
10:05 AM - 10:10 AM Performance Goals And Clinical Trial Designs To Permit Rapid Accurate Evaluation Of Safety And Efficacy Of CLI Treatment Devices
  Presenters(s):Michael S. Conte, MD  
10:11 AM - 10:16 AM Are We Making Progress In The Endovascular Treatment Of SFA Disease Or Will All Treatments Prove Equally Ineffective: Is The High Cost Worth The Price?
  Presenters(s):Kenneth Rosenfield, MD  
10:17 AM - 10:22 AM Endo First vs. Open First For CLI: Is The BASIL Trial Applicable In 2010: Is It Still Helpful?
  Presenters(s):Andrew W. Bradbury, MD, FRCSEd  
10:23 AM - 10:28 AM Long-Term Outcomes Of Endovascular Infrainguinal Treatments: Are They A Viable Modality Or A Revenue Generator?
  Presenters(s):Clifford J. Buckley, MD  
10:29 AM - 10:34 AM Late Results (3-5 Years) After Endovascular Treatment Of Crural And Pedal Disease Causing CLI
  Presenters(s):Roberto Ferraresi, MD  
10:35 AM - 10:40 AM Endovascular Techniques For Limb Salvage In Diabetics With Crural And Pedal Disease – Including Pedal Loop Techniques
  Presenters(s):Marco G. Manzi, MD  
10:41 AM - 10:46 AM Early And Mid-Term Results Of Transpedal Revascularization Procedures
  Presenters(s):Andrej Schmidt, MD, PhD  
10:47 AM - 10:52 AM Tricks For Crossing Total Occlusions In Lower Extremity Arteries
  Presenters(s):Tony S. Das, MD  
10:53 AM - 10:59 AM Panel Discussion
Moderator(s): Kenneth Ouriel, MD, FACS, FACC / George H. Meier III, MD  
11:00 AM - 11:05 AM Results Of Randomized Controlled Trial (RCT) Comparing Drug Eluting Stent (Zilver PTX) With PTA And Bare Metal Stent For SFA And Popliteal Lesions
  Presenters(s):Michael D. Dake, MD  
11:06 AM - 11:11 AM Results Of RCT Comparing Paclitaxil Coated Balloons With Uncoated Balloons For PTA In The SFA And Proximal Popliteal Artery (PACURA I Trial)
  Presenters(s):Johannes Lammer, MD  
11:12 AM - 11:17 AM Tips And Tricks For Treating Lower Extremity Occlusions In The SFA, Popliteal And Tibial Arteries: Can They All Be Crossed And How?
  Presenters(s):Thomas Zeller, MD  
11:18 AM - 11:23 AM Treatment Of In-Stent Restenosis: Is There Anything That Works?
  Presenters(s):John R. Laird, MD  
11:24 AM - 11:29 AM An Overview Of Drug Eluting Balloons: So Many Companies: So Many Trials: Where Are We And Where Are We Going?
  Presenters(s):Gunnar Tepe, MD  
11:30 AM - 11:35 AM Subintimal Recanalization Of Occluded Stents: The “Substent Technique”
  Presenters(s):Konstantinos Katsanos, MD  
11:36 AM - 11:41 AM Value Of Stem Cells From Bone Marrow In Otherwise Untreatable Patients With CLI Facing Amputation: It Works
  Presenters(s):Ralf R. Kolvenbach, MD  
11:42 AM - 11:47 AM Heparin Bonded PTFE vs. Vein In Below-Knee Bypasses: The U.S. And European Experience
  Presenters(s):Richard F. Neville, MD  
11:48 AM - 11:55 AM Panel Discussion
11:55 AM - 1:00 PM Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
Web-Based Presentation 17.1 - Comparison Of Endovascular-First vs. Surgical Revascularization-First For Limb Salvage In CLI: 5-Year Results Are Similar
  Presenters(s):Mauri J.A. Lepantalo, MD  
Web-Based Presentation 17.2 - Role And Value Of The SUPERA Hi Radial Force Stent In Treating Calcified And Resistant SFA Lesions
  Presenters(s):Dierk Scheinert, MD  
Web-Based Presentation 17.3 - Value Of The ROTAREX System For In-Stent Restenosis At The Level Of The Iliac And Femoro-Popliteal Arteries
  Presenters(s):Gioacchino Coppi, MD  
Web-Based Presentation 17.4 - What Is The Best Technique And Device For Mechanical Thrombectomy With Lower Extremity Arterial Lesions?
  Presenters(s):Andrej Schmidt, MD, PhD  
END OF SESSION 17
 
SESSION 18 SCHEDULE
Thursday
SESSION 18: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators:Rajiv Parakh, MBBS, MS, FRCS / Frank J. Veith, MD  
x
1:00 PM - 1:05 PM Preserving Spinal Cord Vascularization With TEVAR: From Theory To Practice
  Presenters(s):Germano Melissano, MD  
1:06 PM - 1:11 PM Advantages Of The Cook PROFORM Thoracic Graft: Initial Clinical Experience
  Presenters(s):Timothy A. Resch, MD, PhD  
1:12 PM - 1:17 PM An Improved Thoracic Endograft For Tight Radius Aortic Arches: Advantages And Initial Clinical Experience
  Presenters(s):Peter R. Taylor, MA, MChir, FRCS  
1:18 PM - 1:23 PM New Developments In Thoracic Endografting And What Is On The Horizon
  Presenters(s):Michael D. Dake, MD  
1:24 PM - 1:29 PM Use Of Vascular Occluding Devices For Treating Reentry Tears In Patients With Persistent False Lumens After Endograft Treatment Of Type B Aortic Dissections
  Presenters(s):Wei Guo Fu, MD  
1:30 PM - 1:35 PM Debate 6: TAAAs Will All Be Treated With Endovascular Techniques
  Presenters(s):Peter L. Harris, MD, FRCS  
1:36 PM - 1:41 PM Debate 6: That’s Nonsense: Some TAAAs Are And Will Always Best Be Treated By Open Repair
  Presenters(s):Hazim J. Safi, MD  
1:42 PM - 1:47 PM Panel Discussion
Moderator(s): Robert B. Rutherford, MD / Mario Lachat, MD  
1:47 PM - 1:52 PM Debate 7: We Still Need A Randomized Controlled Trial (RCT) Of EVAR vs. Open Repair (OR) For Ruptured AAAs: The Ongoing (AJAX And ECAR) Trials Prove It
  Presenters(s):Willem Wisselink, MD / Jean-Pierre Becquemin, MD, FRCS / Marc R.H. van Sambeek, MD, PhD  
1:53 PM - 1:58 PM Debate 7: RCTs Of EVAR And OR In Ruptured AAAs Are A Waste Of Time And Will Provide No Useful Information
  Presenters(s):Dieter O. Mayer, MD  
1:59 PM - 2:04 PM EVAR And OR For Ruptured AAA Produce Equal Mortality Rates: Other Factors Like Organization And Fluid Management Are More Important Than The Method Of Repair
  Presenters(s):Jürg Schmidli, MD  
2:05 PM - 2:10 PM “EVAR Suitable Anatomy” Is A Favorable Factor For Open Repair Of Ruptured AAAs And Results In Better Outcomes: Maybe We Do Need A RCT But It Will Be Impossible To Carry Out
  Presenters(s):Florian Dick, MD  
2:11 PM - 2:16 PM Do Endoleaks After EVAR For RAAA Matter: How Should They Be Dealt With?
  Presenters(s):Benjamin W. Starnes, MD  
2:17 PM - 2:22 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 18.1 - Management Of Spinal Ischemia After Endovascular Repair Of TAAs Or TAAAs
  Presenters(s):Timothy A.M. Chuter, DM  
Web-Based Presentation 18.2 - Prevention Of Spinal Cord Complications With TEVAR
  Presenters(s):John E. Connolly, MD  
Web-Based Presentation 18.3 - Resolving The Continuing Confusion Over Acute And Chronic Type B Aortic Dissections: Why Is The Distinction Crucial: An Endovascular Therapist’s Perspective
  Presenters(s):Frank J. Criado, MD, FACS, FSVM  
Web-Based Presentation 18.4 - TEVAR And Covering The Celiac Artery: Is It Safe Or Not?
  Presenters(s):Lars Lonn, MD, PhD  
END OF SESSION 18
 
SESSION 19 SCHEDULE
Thursday
SESSION 19: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2010 (5-MINUTE TALKS)
Moderators:Thomas S. Riles, MD / Anne L. Abbott, MD, PhD, FRACP  
x
2:22 PM - 2:27 PM Ten Top Tips For SAFE CAS: A Neuroradiologist’s Perspective
  Presenters(s):Emmanuel M. Houdart, MD  
2:28 PM - 2:33 PM Debate 8: CREST Has Restored CAS To Its Rightful Place As Best Treatment For Most Carotid Stenoses: An Interventionalist’s Perspective
  Presenters(s):William A. Gray, MD  
2:34 PM - 2:39 PM Debate 8: CREST May Be Helpful To Advocates Of CAS But It Is Not The Final Answer: When CEA, When CAS, When Best Medical Treatment (BMRx): A Surgeon’s Perspective
  Presenters(s):Wesley S. Moore, MD  
2:40 PM - 2:45 PM Debate 8: Subanalysis Of CREST Results Are Important: Were There Differences Between CAS And CEA In 1) Quality Of Life And 2) Cost Effectiveness; What Were The Severity And Disability From The MIs And The Cranial Nerve Injuries: A Neurologist’s Perspective
  Presenters(s):Thomas G. Brott, MD  
2:46 PM - 2:51 PM The Woes Of CAS Are Not Fully Solved By CREST: When Is CAS Justified And When And Why Is It Not?
  Presenters(s):Frank J. Criado, MD, FACS, FSVM  
2:52 PM - 2:57 PM Debate 9: We Do Not Need Any More CAS Trials After CREST And ICSS
  Presenters(s):Mark H. Wholey, MD  
2:58 PM - 3:03 PM Debate 9: We Need Additional CAS Trials And Why
  Presenters(s):Andrew N. Nicolaides, MS, FRCS  
3:04 PM - 3:09 PM Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For Treatment By CEA Or CAS In Most Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease
  Presenters(s):John (Jeb) W. Hallett, MD  
3:10 PM - 3:15 PM Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For CEA Or CAS, In Some Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease
  Presenters(s):John J. Ricotta, MD  
3:16 PM - 3:21 PM Debate 10: Most Patients Undergoing Cardiac Surgery With Asymptomatic Carotid Disease Do Not Benefit From A Synchronous Or Staged Carotid Intervention
  Presenters(s):A. Ross Naylor, MD, FRCS  
3:22 PM - 3:27 PM Panel Discussion
Moderator(s): Frank J. Veith, MD / Mark H. Wholey, MD  
3:27 PM - 3:32 PM Are There Neuropsychological Complications Of CAS Or CEA In The Absence Of Strokes?
  Presenters(s):Wei Zhou, MD  
3:33 PM - 3:38 PM CAS vs. CEA: What Are The DWI MRA, Brain Damage Markers And Neuropsychological Consequences Of The Two Procedures In Asymptomatic Patients: An Update
  Presenters(s):Laura Capoccia, MD  
3:39 PM - 3:44 PM SPACE II: The Most Needed Comparison Of CAS, CEA And BMRx For Asymptomatic Disease: Will It Provide Answers And When?
  Presenters(s):Hans-Henning Eckstein, MD, PhD  
3:45 PM - 3:50 PM When Is Cessation Or Reversal Of Brain Flow Protection A Must In CAS: What Are Its Disadvantages?
  Presenters(s):L. Nelson Hopkins, MD  
3:51 PM - 3:56 PM National Database Update On CEA vs. CAS For Symptomatic And Asymptomatic Disease: Are CAS Results Improving?
  Presenters(s):Mohammad H. Eslami, MD, RVT  
3:57 PM - 4:02 PM Serial Duplex Measurements Of Asymptomatic Carotid Lesions: Will They Help Identify Patients At Higher Risk For Stroke Who Will Benefit More From Invasive Treatment?
  Presenters(s):Alison Halliday, MS, FRCS  
4:03 PM - 4:08 PM How Can Asymptomatic Patients With Carotid Stenoses Be Identified To Be At High Stroke Risk In The Statin Era?
  Presenters(s):J. David Spence, MD  
4:09 PM - 4:15 PM Panel Discussion
4:15 PM - 4:25 PM Break – Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 19.1 - Toward Safer CAS: Tips And Tricks
  Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
Web-Based Presentation 19.2 - Does The CRYSTALLO Variable Cell Size Stent Lower Embolic Event Rates With CAS?
  Presenters(s):Alberto Cremonesi, MD, FESC  
Web-Based Presentation 19.3 - Right Brachial Approach For Left Carotid Stenting With A Bovine Arch Anatomy
  Presenters(s):Patrick E. Muck, MD, RVT, FACS  
Web-Based Presentation 19.4 - Radial Approach For CAS: When, Why And How
  Presenters(s):Ali Amin, MD, RVT, FACS, FACC  
Web-Based Presentation 19.5 - Flaws In The Empire Trial
  Presenters(s):Michael H. Wholey, MD, MBA  
Web-Based Presentation 19.6 - Will The TACIT Trial Ever Be Done?
  Presenters(s):Barry T. Katzen, MD  
END OF SESSION 19
 
SESSION 20 SCHEDULE
Thursday
SESSION 20: NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS AND STENTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Timur P. Sarac, MD  
x
4:25 PM - 4:30 PM Update On The VIBRANT And VIPER Trials Showing The Value Of Endoluminal Bypass With The Viabahn Stent-Graft For Long SFA Disease
  Presenters(s):Gary M. Ansel, MD  
4:31 PM - 4:36 PM RCT Of Viabahn Stent Grafts With Heparin Bonding vs. Bare Nitinol Stents In SFA Disease (The VIASTAR Trial): The Importance Of Edge Stenosis
  Presenters(s):Johannes Lammer, MD  
4:37 PM - 4:42 PM Endovascular Stent-Graft Treatment Of Popliteal Aneurysms With Only Duplex Guidance
  Presenters(s):Enrico Ascher, MD  
4:43 PM - 4:48 PM Are Stent-Grafts Better Than Bare Metal Stents For Treating Iliac Artery Occlusions (The COBEST Trial): What Is Their History And Limitations?
  Presenters(s):Patrice B. Mwipatayi, FRACS  
4:49 PM - 4:54 PM Results With Second Generation Tissue Covered Stent-Grafts In The SFA And Popliteal Arteries
  Presenters(s):Albrecht H. Krämer, MD / Timur P. Sarac, MD / Francisco Valdes, MD  
4:55 PM - 5:00 PM What Is The Future For Biodegradable Stents And Biodegradable Polymers?
  Presenters(s):Ron Waksman, MD  
5:01 PM - 5:06 PM Evolving Experience With Intracranial Stents: The Good And The Bad
  Presenters(s):L. Nelson Hopkins, MD  
5:07 PM - 5:12 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 20.1 - Debate: Open Surgery Is Still The Primary Approach For CLI
  Presenters(s):R. Clement Darling III, MD  
Web-Based Presentation 20.2 - Debate: Endovascular Treatments Should Be The Primary Approach For CLI: But Not For All Patients
  Presenters(s):Ali Amin, MD, RVT, FACS, FACC  
Web-Based Presentation 20.3 - Are Failed Stent-Grafts In The SFA More Likely To Lead To CLI Than Failed Stents Or POBA?
  Presenters(s):Gary M. Ansel, MD  
Web-Based Presentation 20.4 - How Can Computer Modeling Help To Design Better Stents For Treating Fempop Occlusive Disease?
  Presenters(s):Jörn O. Balzer, MD, PhD  
Web-Based Presentation 20.5 - Nitinol Stents Can Be Effective Across The Knee Joint
  Presenters(s):Luis R. Leon, MD, RVT, FACS  
END OF SESSION 20
 
SESSION 21 SCHEDULE
Thursday
SESSION 21: NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (4 AND 5-MINUTE TALKS)
Moderators:James F. McKinsey, MD / Frank J. Veith, MD  
x
5:12 PM - 5:17 PM Overview Of Established And New Antiplatelet Agents
  Presenters(s):Gregg W. Stone, MD  
5:18 PM - 5:23 PM Treatment Of Multiple Sclerosis By Interventional Procedures To Reduce Venous Obstruction: When Is It Helpful And When Is It Not?
  Presenters(s):Paolo Zamboni, MD  
5:24 PM - 5:29 PM Radiofrequency Periarterial Nerve Ablation From Within The Renal Artery To Treat Resistant Hypertension: Does It Work And How?
  Presenters(s):Dierk Scheinert, MD  
5:30 PM - 5:35 PM Importance Of Previously Undetected Arrhythmias In High Risk Vascular Surgery Patients: The REVEAL Monitoring Device And How It Can Help Patient Management
  Presenters(s):Hence J.M. Verhagen, MD, PhD  
5:36 PM - 5:41 PM Difficult A-V Malformations Can Be Treated Effectively But It Is Hard: Tips And Tricks
  Presenters(s):Furuzan Numan, MD  
5:42 PM - 5:47 PM How To Start An A-V Malformation Program: Absolute Ethanol Can Be Dangerous But Helpful
  Presenters(s):Iris Baumgartner, MD  
5:48 PM - 5:52 PM A Simple Way To Understand And Treat Vascular Malformations
  Presenters(s):Peter Gaines, MD  
5:53 PM - 5:58 PM Treatment Of Angiodysplasia: Dirty Laundry And Lessons Learned
  Presenters(s):Byung-Boong Lee, MD  
5:59 PM - 6:04 PM Update On Stem Cell Therapy For CLI And Heart Failure: Will It Work?
  Presenters(s):Alan Dardik, MD, PhD  
6:05 PM - 6:10 PM Update On The Status Of Gene Therapy For CLI: Will It Work?
  Presenters(s):Richard J. Powell, MD  
6:11 PM - 6:16 PM Panel Discussion
Web-Based Presentation 21.1 - Are Stem Cells Going To Become Widely Used For CLI?
  Presenters(s):Iris Baumgartner, MD  
END OF SESSION 21
 
SESSION 22 SCHEDULE
Thursday
SESSION 22: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Barry T. Katzen, MD / Kumud Rai, MD  
x
6:16 PM - 6:21 PM Systemic Inflammatory Response Syndrome (SIRS) And Its Importance In Vascular And Endovascular Procedures: What Is It And How Should It Be Diagnosed And Treated?
  Presenters(s):Torben V. Schroeder, MD, DMSc / Lars Lonn, MD, PhD  
6:22 PM - 6:27 PM What Is The Best Way To Minimize Brain Damage During CAS: Reversal Of Flow vs. Filter vs. No EPD: A Comparative Study Using DWI And Brain Enzymes As End Points
  Presenters(s):Peter Gaines, MD  
6:28 PM - 6:33 PM Spiral Saphenous Vein Graft Reconstruction For Aortic Graft Infection: An Alternative For The Clagett-Nevelsteen Procedure Using Femoral (Deep) Vein Grafts
  Presenters(s):Jan M.M. Heyligers, MD, PhD  
6:34 PM - 6:39 PM Initial Clinical Experience With A New Low Profile AAA Stent-Graft Device (INCRAFT) From Cordis
  Presenters(s):Dierk Scheinert, MD  
6:40 PM - 6:45 PM Debate 11: What Advances In Percutaneous Femoral Access Make It The Preferred Method For All Large Sheath Endovascular Procedures: A New Sheath To Minimize Blood Loss
  Presenters(s):Claude Mialhe, MD  
6:46 PM - 6:51 PM Debate 11: Tips And Tricks For Percutaneous Access For EVAR And TEVAR (Video)
  Presenters(s):Carlos H. Timaran, MD  
6:52 PM - 6:57 PM Debate 11: The Case Against “Preclose” Percutaneous Closure For Routine EVAR And TEVAR
  Presenters(s):Frank J. Criado, MD, FACS, FSVM  
6:58 PM - 7:03 PM Is Fascial Closure Equal To Or Better Than Prostar Preclose Technique After Large Sheath Insertion: A Comparative Study
  Presenters(s):Thomas Larzon, MD  
7:04 PM - 7:15 PM Panel Discussion
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 22.1 - Fascial Closure (Larzon Technique) After EVAR And TEVAR Works If Done Right And Is Cheaper: Experience In 100 Cases
  Presenters(s):Timothy A. Resch, MD, PhD  
Web-Based Presentation 22.2 - Versatility Of The Fibrenet System For Brain Protection During CAS: Advantages And Limitations
  Presenters(s):Gary M. Ansel, MD  
Web-Based Presentation 22.3 - Tips And Tricks For Arterial Puncture To Avoid Complications
  Presenters(s):Jos C. van den Berg, MD, PhD  
Web-Based Presentation 22.4 - Importance Of Fluvostatin In Vascular Surgery Patients: Optimal Dosing And Administration
  Presenters(s):Don Poldermans, MD  
Web-Based Presentation 22.5 - Bivalrudin For Anticoagulation: What Is Its Value For Peripheral Interventions?
  Presenters(s):Barry T. Katzen, MD  
END OF SESSION 22